How eukaryotic cells sense availability of glucose, their preferred carbon and energy source, is an important, unsolved problem. Bakers' yeast (Saccharomyces cerevisiae) uses two glucose transporter homologs, Snf3 and Rgt2, as glucose sensors that generate a signal for induction of expression of genes encoding hexose transporters (HXT genes). We present evidence that these proteins generate an intracellular glucose signal without transporting glucose. The Snf3 and Rgt2 glucose sensors contain unusually long C-terminal tails that are predicted to be in the cytoplasm. These tails appear to be the signaling domains of Snf3 and Rgt2 because they are necessary for glucose signaling by Snf3 and Rgt2, and transplantation of the C-terminal tail of Snf3 onto the Hxt1 and Hxt2 glucose transporters converts them into glucose sensors that can generate a signal for glucose-induced HXT gene expression. These results support the idea that yeast senses glucose using two modified glucose transporters that serve as glucose receptors.
Introduction
Glucose, the preferred carbon and energy source for most eukaryotic cells, has significant and varied effects on cell function. Consequently, maintaining glucose homeostasis is of great importance to many organisms. How cells perceive and respond to glucose is an important, unanswered question. A signal transduction pathway responsible for glucose-induced gene expression in baker's yeast (Saccharomyces cerevisiae) has come into focus recently. Transcription of several of the 20 genes that encode hexose transporters or highly related proteins (HXT genes) (Bisson et al., 1993; Kruckeberg, 1996; Boles and Hollenberg, 1997 ) is induced by glucose. Expression of HXT1 is induced only in response to high concentrations of glucose; transcription of HXT2 and HXT4 is induced only by low levels of glucose Johnston, 1995, 1996; Schulte and Ciriacy, 1995) . Glucose induction of the HXT genes is mediated by a repression mechanism involving the zinc-finger-containing protein Rgt1: in the absence of glucose, Rgt1 binds to the HXT promoters and represses their expression; glucose inactivates Rgt1 repressor function, leading to derepression of HXT expression (Marshall-Carlson et al., 1991; Erickson and Johnston, 1994; Ö zcan and Johnston, 1995; Ö zcan et al., 1996a) . Inhibition of Rgt1 by glucose requires Grr1, which may be part of a ubiquitin-conjugating enzyme complex (Flick and Johnston, 1991; Barrall et al., 1994; Vallier et al., 1994; Li and Johnston, 1997) .
The glucose signal that triggers inhibition of Rgt1 function appears to be generated by Snf3 and Rgt2 (Ö zcan et al., 1996b) , which are similar to glucose transporters and are members of a large family of 20 known or predicted glucose transporters in yeast. Most of these Hxt proteins are very similar to each other, sharing between 50 and 100% amino acid sequence identity. Snf3 and Rgt2 are the most divergent family members, being only~25% similar to their relatives (Bisson et al., 1993; Kruckeberg, 1996; Boles and Hollenberg, 1997) . A distinguishing characteristic of Snf3 and Rgt2 is their unusually long C-terminal extensions (Ͼ200 amino acids) that are predicted to reside in the cytoplasm (Marshall-Carlson et al., 1990) . All other known or predicted hexose transporters (from any organism) have C-terminal cytoplasmic tails of only~50 amino acids.
Work in several laboratories suggested that Snf3 plays a regulatory rather than a metabolic role in glucose transport (Marshall-Carlson et al., 1990 Bisson et al., 1993; Ko et al., 1993; Ö zcan and Johnston, 1995; Liang and Gaber, 1996; Coons et al., 1995 Coons et al., , 1997 . We have presented evidence that Snf3 and Rgt2 are sensors of extracellular glucose that are involved in generation of an intracellular glucose signal that triggers the induction of HXT gene expression (Ö zcan et al., 1996b) . The key result that led to this idea is that a dominant mutation in RGT2 and SNF3 (Marshall-Carlson et al., 1990) causes constitutive induction of HXT gene expression, even in the absence of the inducer glucose (Ö zcan et al., 1996b) . We believe this mutation converts the glucose sensors into their glucose-bound form. This result led us to conclude that glucose sensing and signaling is a receptor-mediated process which is independent of glucose metabolism. Here we provide further evidence that glucose signaling is not the result of glucose transport and that the C-termini of Rgt2 and Snf3 are the glucose signaling domains of these glucose sensors.
Results

Snf3 and Rgt2 have separate but overlapping functions
Previous results indicated that Snf3 and Rgt2 probably sense different levels of glucose (Ö zcan et al., 1996b) ; Snf3 seems to function as a sensor of low levels of glucose because it is required for low glucose-induced expression (Table I, line 12B) . Consequently, the snf3 rgt2 double mutant grows poorly on high concentrations of glucose ( Figure 3 ; see below). This is in contrast to snf3 mutants, which exhibit no reduction of high glucoseinduced HXT1 expression (line 9B), and rgt2 mutants, which have only~5-to 6-fold reduction in HXT1 transcription at high concentrations of glucose (line 6B) (Ö zcan et al., 1996b) . Thus, Snf3 appears to contribute to induction of HXT1 transcription by high levels of glucose. We believe that these results reflect the different relative affinities of these sensors for glucose: Rgt2 is probably a sensor of high levels of glucose (a low-affinity receptor); Snf3 is probably a sensor of low levels of glucose (a highaffinity receptor; see Discussion).
Snf3 and Rgt2 are limiting components of the glucose signaling pathway Previous data obtained with dominant SNF3-1 and RGT2-1 mutants suggested that these two proteins are the limiting components of the glucose signaling pathway (Ö zcan et al., 1996b) . This is supported by the observation that overexpression of either SNF3 or RGT2 causes constitutive expression of HXT1 and HXT2 (i.e. even in the absence of glucose) ( Table I , lines 4A and 4C, and lines 5A and 5C). We believe this is because the glucose receptors, like all receptors, are in equilibrium between the unliganded and ligand-bound form. Higher levels of the receptors necessarily increase the amount of receptor in the ligandbound form, leading to constitutive signaling. Note that HXT1 expression in the absence of glucose is only partially constitutive (lines 4A and 5A); this is because induction of HXT1 expression at high levels of glucose requires a second, Rgt2-independent pathway (Ö zcan et al., 1996b) .
Glucose transport is neither necessary nor sufficient for signaling
To test whether Snf3 and Rgt2 can transport glucose, we expressed them in a strain unable to grow on glucose because it is deleted for seven HXT genes (hxt1Δ-hxt7Δ, called the hxt null mutant) (Reifenberger et al., 1995 (Reifenberger et al., , 1997 (Figure 1 ). Expression in this strain of any one of the seven HXT genes restores growth on glucose (Reifenberger et al., 1995) . We overexpressed in this strain SNF3, RGT2 and HXT1 from the ADH1 promoter on a multicopy plasmid and assayed growth on glucose media. Overexpression of HXT1 fully restored growth of the hxt null strain. By contrast, neither SNF3 nor RGT2, when overexpressed, were able to restore growth of the hxt null mutant (Figure 1 ). While we cannot be certain that increased levels of Rgt2 and Snf3 are expressed and reach the membranes in these cells, the fact that expression of SNF3 and RGT2 from the ADH1 promoter leads to constitutive HXT gene expression (Table I, lines 4A, 4C, 5A and 5C) suggests that this is the case. Thus, even though they are similar to glucose transporters, Snf3 and Rgt2 appear unable to transport sufficient amounts of glucose to correct the growth defect of the hxt null mutant.
To test if bona fide glucose transporters can provide for glucose signaling, we expressed the HXT1 and HXT2 genes from the ADH1 promoter on a multicopy plasmid in snf3 and rgt2 mutant cells and tested for restoration of HXT gene expression (Table II) . Both of these plasmids express functional glucose transporters because they enable a mutant defective in glucose transport to grow on glucose ( Figure 1 , and data not shown), but neither is able to restore the glucose signaling defect of snf3 or rgt2 mutants, indicating that the HXT induction defect in these mutants is not due simply to impaired glucose transport.
The C-terminal tails of Snf3 and Rgt2 are necessary for glucose signaling An unusual feature of Snf3 and Rgt2 that distinguishes them from all other known glucose transporters is their long C-terminal tails, which are predicted to reside in the cytoplasm. The sequences of the Snf3 and Rgt2 tails are dissimilar, except for a stretch of 25 amino acids, 16 of which are identical among the repeats. Snf3 has two of these sequences; Rgt2 has only one ( Figure 2) . Deletion of the Rgt2 C-terminal tail (RGT2Δ2) abolishes its ability to sense high levels of glucose and induce HXT1 expression (Table III , line 3B), and deletion of the Snf3 tail (SNF3Δ2) abolishes its ability to sense low levels of glucose and induce HXT2 expression (line 7D). Furthermore, the dominant mutations SNF3-1 and RGT2-1 (Arg231 and Arg229, respectively, changed to lysine), which cause constitutive (glucose-independent) expression of the HXT genes (Table III , lines 10A and C, and 12A and C; see and ADH1-HXT1 was scored for growth on YNB medium containing either 2% galactose or 2% glucose with antimycin A (1 μg/ml). The cells were grown first on YNB medium lacking uracil with 2% galactose as carbon source and then replica plated on YNB medium containing 2% glucose with antimycin A. ADH-HXT2 9 Ϯ 1 3 7 Ϯ 6 a Abbreviations: see Table I ; vector ϭ pRS426; ADH-HXT1 ϭ pBM3362; ADH-HXT2 ϭ pBM3138.
2568 also Ö zcan et al., 1996b), do not manifest their effect when the C-terminal tails of Snf3 and Rgt2 are deleted (lines 11A and C, and 13A and C). Thus, the C-terminal tails of both Snf3 and Rgt2 are essential for glucose signaling. The 25 amino acid repeats seem to be the functional units of the C-terminal tails of Snf3 and Rgt2 because an Rgt2 protein that retains its 25 amino acid repeat but is missing all distal sequences (RGT2Δ1) is still partially functional, mediating 2-fold induction of HXT1 expression (Table III , compare lines 1B, 2B and 4B). Similarly, Snf3 retaining one of its two repeats (SNF3Δ1) is partially functional, providing~3-fold induction of HXT2 expression (compare lines 5D, 6D and 8D). However, overexpression of the Snf3 or Rgt2 tails by themselves does not restore the glucose signaling defect of snf3 or rgt2 mutants (Table IV, lines 3B, 4B, 7D and 8D). Thus, the C-terminal Table I ; vector ϭ pRS316; CEN-RGT2 ϭ pBM3272; RGT2Δ1 ϭ pBM3312; RGT2Δ2 ϭ pBM3279; CEN-SNF3 ϭ pBM3111; SNF3Δ1 ϭ pBM3319; SNF3Δ2 ϭ pBM3363; RGT2-1 ϭ pBM3270; RGT2-1ΔT ϭ pBM3277; SNF3-1 ϭ pBM3259; SNF3-1ΔT ϭ pBM3335. 
a Abbreviations: see Table I ; vector ϭ pRS426; CEN-RGT2 ϭ pBM3272; CEN-SNF3 ϭ pBM3111; SNF3-T ϭ pBM3578; RGT2-T ϭ pBM3576.
tails of Rgt2 and Snf3 are necessary, but are not by themselves sufficient, for signaling.
Attachment of the Snf3 C-terminus to Hxt1 and Hxt2 converts these glucose transporters into glucose sensors
To test whether the C-terminal tail of Snf3 allows glucose signaling when attached to other glucose transporters, we attached it to the Hxt1 and Hxt2. Indeed, both HXT1-SNF3 and HXT2-SNF3 chimeras partially complement the signaling defect of snf3 and rgt2 mutants (Table V, lines 3B, 4B, 8D and 9D). Since neither wild-type HXT1 nor HXT2 could repair the signaling defect of snf3 and rgt2 mutants (even when overexpressed) (Table II) , we conclude that the C-terminal tail of Snf3 confers upon these glucose transporters the ability to signal glucose availability. However, these chimeric proteins do not signal as well as Snf3 or Rgt2, indicating that other residues of Snf3 and Rgt2 (probably in the transmembrane domain) are important for optimal function of the glucose sensors. Overexpression of the HXT1-SNF3 chimera from the ADH1 promoter in the snf3 and rgt2 mutant strain also causes a low level of constitutive HXT expression (i.e. in the absence of glucose) (Table V, lines 5A and 10C). This is similar to results obtained when SNF3 and RGT2 were overexpressed (Table I) , and further supports the view that the concentration of glucose sensors is the limiting factor for signaling.
Snf3 and Rgt2 are required for glucose repression of GAL1 and SUC2 expression
The snf3 rgt2 double mutant is severely defective in induction of HXT expression (like grr1 mutants), and therefore grows poorly on glucose-containing media. Overexpression of HXT1 (from the ADH1 promoter on a multicopy plasmid) in the snf3 rgt2 double mutant restores growth of this mutant on glucose (Figure 3) , suggesting that its poor growth on glucose is due to a defect in glucose transport. Overexpression of HXT1 does not, however, repair the glucose induction defect in HXT expression (Table I , lines 13B and D), supporting the idea that the glucose induction signal is generated independently of glucose metabolism.
Because the snf3 rgt2 double mutant has severely reduced glucose transport, we expected it to be defective in glucose repression of GAL1 and SUC2 expression (like grr1 mutants) (Flick and Johnston, 1991; Ö zcan et al., 1994) . Indeed, GAL1 and SUC2 expression is not repressed by 4% glucose in the snf3 rgt2 double mutant, in contrast to snf3 or rgt2 single mutants (Table VI) . The snf3 rgt2 double mutant displays a 3-fold decrease in SUC2 expression at low concentrations of glucose because low levels of glucose induce SUC2 expression, and this requires SNF3 (Ö zcan et al., 1997).
Discussion
Snf3 and Rgt2 appear to serve as sensors of glucose that generate an intracellular glucose signal for induction of HXT gene expression in yeast. Even though both proteins are very similar to glucose transporters, they apparently do not transport glucose, since they do not enable a mutant deficient in glucose transport to grow on glucose ( Figure  1 ). There are two possible explanations for this observation; Snf3 and Rgt2 could bind glucose without being able to translocate it across the plasma membrane, or they could transport glucose, but with a capacity insufficient to allow growth of the hxt null mutant on glucose. Since both proteins should be present in cells at relatively high levels in our experiment (they were expressed from the strong ADH1 promoter on a multicopy plasmid, and this causes constitutive glucose signaling), we favor the idea that Snf3 and Rgt2 do not translocate glucose, but are instead glucose receptors. Conversely, transport of glucose does not appear to be sufficient for generation of the glucose signal because overexpression of the bona fide glucose transporters HXT1 or HXT2 does not restore the glucose signaling defect of snf3 or rgt2 mutants. This indicates that the signaling defect of these mutants is not due simply to impaired glucose transport. The facts that Snf3 and Rgt2 do not seem to transport glucose, and that known glucose transporters are unable to signal glucose availability bolsters our confidence in the idea that Snf3 and Rgt2 are glucose receptors that generate an intracellular signal for induction of gene expression.
The snf3 rgt2 double mutant is completely defective in glucose induction of HXT expression, in contrast to the single mutants (Table I) . As a consequence, this double Table I ; vector ϭ pRS316; GAL1::lacZ ϭ pBM690; SUC2::lacZ ϭ pBM3082.
mutant is defective in glucose transport and grows poorly on glucose-containing media. Because of its glucose transport defect, the snf3 rgt2 mutant is also defective in glucose repression of GAL1 and SUC2 expression (like grr1 mutants) (Table VI) . Even though the growth defect of the snf3 rgt2 double mutant on glucose is corrected by overexpression of HXT1, the defect in glucose induction of HXT expression is not, lending further support to the idea that the signal for glucose induction is generated independently of glucose metabolism. Induction of HXT1 expression by high levels of glucose is reduced~5-fold in an rgt2 mutant, but is unaffected by a snf3 mutation. Induction of HXT2 expression by low levels of glucose is abolished in a snf3 mutant, but unaffected by an rgt2 mutation. This suggests that the two proteins have different affinities for glucose; Rgt2 appears to be a sensor of high levels of glucose (a low-affinity receptor) and Snf3 appears to be a sensor of low levels of glucose (a high-affinity receptor). Snf3 also contributes to high glucose induction of HXT1 transcription because the snf3 rgt2 double mutant has a more severe defect in high glucose-induced HXT1 expression than the rgt2 single mutant (Table I, line 12) . A function for Snf3 at high concentrations of glucose was also suggested by the observation that it is required for repression of HXT6 and HXT7 expression at high levels of glucose (Liang and Gaber, 1996) . This is expected behavior for a high-affinity receptor, since it should bind ligand at both low and high concentrations. SNF3 expression is repressed by glucose (Celenza et al., 1988; Bisson et al., 1993; Ö zcan and Johnston, 1995) , but the basal level of SNF3 expression apparently is sufficient to provide enough Snf3 under glucose repression conditions for it to sense glucose and generate the intracellular signal.
Rgt2, presumably being a low-affinity glucose receptor, is expected to sense only high levels of glucose. Indeed, rgt2 mutations have no effect on low glucose-induced expression of HXT2 (Table I ; also see Ö zcan et al., 1996b) . Recent results of Jiang et al. (1997) support the idea that Rgt2 functions as a high glucose sensor; Rgt2, but not Snf3, is required for normal inactivation of the maltose permease caused by high levels of glucose. In addition, the dominant RGT2-1 mutation causes constitutive degradation of maltose permease (even in the absence of glucose) (Jiang et al., 1997) .
The long C-terminal extensions of Snf3 and Rgt2, which are predicted to reside in the cytoplasm, distinguish these proteins from the yeast Hxt proteins and glucose transporters of many other organisms. The sequences of these tails are similar only in a 25 amino acid repeat (Figure 2) . Our results suggest that these repeats are important for Snf3 and Rgt2 signaling function. At least one of the two repeats in the Snf3 tail is required for induction of HXT2 expression by low levels of glucose (Table III) , consistent with previous observations that at least one of the two repeats in Snf3 is necessary for growth of cells on raffinose (Marshall-Carlson et al., 1990; Bisson et al., 1993) . The repeated sequences in the C-terminal tails of Snf3 and Rgt2 contain putative phosphorylation sites for casein kinase II ( Figure  2 , Bisson et al., 1993) , and conserved glycine residues that might constitute a nucleotide-binding domain (DXGXGX 15-50 GXG; Saraste et al., 1990) .
The C-terminal tail of Snf3 is able to generate an intracellular glucose signal when attached to either Hxt1 or Hxt2. This suggests that Snf3 and Rgt2 consist of two domains: a 12 transmembrane domain responsible for binding glucose and a C-terminal domain in the cytoplasm that transmits the glucose signal to the next intracellular component of the signal transduction pathway. However, because attachment of the Snf3 tail to Hxt1 or Hxt2 results in only partial signaling, other residues in the transmembrane domain of Snf3 and Rgt2 must be important for optimal function of the glucose sensors.
The protein(s) that receives the glucose signal from Snf3 or Rgt2, presumably by interacting with their C-terminal tails, has not been identified. Hxk2, the main glucose-phosphorylating enzyme in yeast, seems a likely candidate because it carries out the first step of glucose metabolism and is partially required for glucose induction of HXT expression (Bisson et al., 1993; Ö zcan and Johnston, 1995) . Yang and Bisson (1996) identified SKS1, which encodes a putative serine/threonine protein kinase, as another candidate. However, we found that deletion of SKS1 has no effect on glucose-induced HXT expression (unpublished result). Recently, a glucose transporter from the yeast Kluyveromyces lactis was identified (RAG4, DDBJ/EMBL/ GenBank accession No. Y14849). It is Ͼ60% identical to Snf3 and Rgt2 from S.cerevisiae. Interestingly, the K.lactis Rag4 protein also has a long C-terminal tail of~251 amino acids that contains one copy of the same repeated sequence found in the C-terminal tails of Snf3 and Rgt2. This finding is consistent with the idea that the 25 amino acid C-terminal repeat plays an important role in signaling by Snf3 and Rgt2. It is possible that Rag4 also functions as a glucose sensor in the yeast K.lactis, and might regulate the high glucose-induced expression of the K.lactis hexose transporter RAG1.
Other transporters of small molecules also function as sensors. Sensing of certain sugars by bacteria is mediated by sugar transporters (Postma et al., 1993; Saier et al., 1996) . However, this cannot be viewed as a receptormediated event, because signal generation is coupled to transport and metabolism (phosphorylation) of the sugar. The glucose transporter Rco3 of Neurospora crassa may function as a nutrient sensor; like Snf3 and Rgt2, it is required for expression of glucose transporter activity, glucose regulation of gene expression and glucose repression (Madi et al., 1997 ). Mep2 appears to play a regulatory role in pseudohypal growth in addition to its function as a high-affinity transporter of ammonium ions (Lorenz and Heitman, 1996) . Thus, sensing and generation of an intracellular signal by transporters in response to nutrients may be a general phenomenon. It seems possible that similar glucose receptors may be found in mammalian cells, possibly in the insulin-producing cells of the pancreas, which must sense the level of available glucose and respond appropriately.
The ability of cells to sense nutrients and respond by altering gene expression is familiar, but doing this by a receptor-mediated process is unusual. Paradigms for how small molecules affect gene expression are provided by the lac operon of Escherichia coli, where an intracellular metabolite of the nutrient lactose (allolactose) induces gene expression by binding to and inhibiting function of the Lac repressor (Schlax et al., 1995) , the GAL genes of S.cerevisiae, where galactose is thought to bind to the Gal3 protein to effect induction of gene expression (Zenke et al., 1996) , and steroid hormones in mammalian cells, which bind to intracellular receptors and modify their ability to affect transcription (Yamamoto, 1995) . In contrast, glucose sensing and signaling by yeast seems to be a receptor-mediated process, more akin to peptide hormone signaling in mammalian cells. The chemotactic response of bacteria, in which certain nutrients are sensed using cell surface receptors and cause altered cell movement, provides one of the few other examples of receptormediated nutrient sensing (Parkinson and Kofoid, 1992) .
Materials and methods
Strains and plasmids
Growth conditions and media have been described previously (Ö zcan and Johnston, 1995) . The strains used in this study are YM4127 (wildtype), YM4718 (rgt2::HIS3) and YM4714 (snf3::hisG). The complete genotype of these strains is described in Ö zcan et al. (1996b) . To construct the rgt2 snf3 double mutant (YM6107), the complete coding region of RGT2 was disrupted in the snf3 mutant YM4714 with a PCR product of GFP-HIS3, as described by Niedenthal et al. (1996) . The hxt null strain (htx1Δ-hxt7Δ, RE700A) was constructed and generously provided by Reifenberger et al. (1995) .
The plasmid pBM3111, containing the SNF3 gene on a CEN vector, was constructed by subcloning the SalI-PstI fragment of pBL8 (MarshallCarlson et al., 1990) containing SNF3 into Ycplac33 (Gietz and Sugino, 1988) . The RGT2-CEN construct (pBM3272) was obtained by PCR amplification of the RGT2 gene as an XbaI-XhoI fragment using the primers OM1018: TGCTCTAGATCCCTTTTTCCTGAAACC (XbaI site at -795 relative to the ATG) and OM1019: CCGCTCGAGGTTG-ACCCATTTTGTATTCC (XhoI site starts 213 bp downstream of the stop codon). The plasmids pBM3135 and pBM3333, which express the SNF3 and RGT2 genes, respectively, from the ADH1 promoter in the multicopy plasmid pRS426, were created by PCR amplification. The SNF3 coding region was amplified as a 2.4 kb HindIII-BamHI fragment with the oligonucleotides OM958: GGCAAGCTTCCATGGACCCTAA-TAGTAACAGTTCTAG (HindIII site starts at the ATG and mutates the natural BamHI site) and OM957: CGCGGATCCCCGCTTAATTAATA-CATCG (BamHI site starts at the stop codon). For the amplification of the RGT2 coding region as an EcoRI-BamHI fragment, the primers OM1124: CCGGAATTCATGAACGATAGCCAAAACTG (EcoRI site starts at ϩ1) and OM1125: CGCGGATCCTTATTGGGGGGAAGTGT-ATTG (BamHI site starts at the stop codon) were used. To create the ADH-HXT1 plasmid (pBM3362), the EcoRV-DraI fragment of HXT1 was subcloned into pRS426 containing the ADH1 promoter as a 0.8 kb HindIII-SalI fragment (pBM2974). The ADH-HXT2 plasmid (pBM3138) was created by subcloning the HXT2 coding region as a BglII-BamHI fragment into pBM2974. The HXT2 gene was amplified by PCR using the oligonucleotides OM1028: GGCAGATCTATGTCTGAATTCGCTA-CTAGC (BglII site starts at the ATG) and OM944: CGCGGATCCCTTA-TTCCTCGGAAACTC (BamHI site starts at the stop codon). The RGT2Δ1 plasmid (pBM3312) that is deleted for all sequences downstream of the RGT2 repeat was constructed by PCR amplification of RGT2 with the oligonucleotides OM1034: CGCGGATCCATGGCGCCCTTGAAA-CTTTC (BamHI site starts at -1200) and OM1126: CCGGAATTCTTAC-CTCATAGAACTCATCAGTAG (EcoRI site starts at ϩ2086), followed by subcloning of the EcoRI-BamHI fragment into pRS316 (Sikorski and Hieter, 1989) . The plasmid containing RGT2Δ2 (pBM3279), which is deleted for the C-terminal tail of RGT2, was created by digesting pBM3272 with SalI (cuts within the RGT2 gene and in the multicloning site of pRS316) followed by religation. The SNF3 deletions SNF3Δ1 (pBM3319) and SNF3Δ2 (pBM3363) are the EcoRI-SalI fragments of the previously described plasmids snf3Δ7-lacZ and snf3Δ10-lacZ (Marshall-Carlson et al., 1990 , but without the lacZ gene), respectively, subcloned into pRS316. Plasmid pBM3259 (SNF3-1) has been described previously (Ö zcan et al., 1996b) . The plasmid containing the dominant RGT2-1 mutation in pRS316 (pBM3270) was created using the same oligonucleotides as described for pBM3272 (OM1018/OM1019). Deletion of the C-terminal tails of RGT2-1 and SNF3-1 was accomplished by cutting pBM3270 with SalI (truncates the tail) and religating to yield pBM3277 (RGT2-1ΔT), and cutting pBM3333 with EcoRV (cuts within the SNF3 tail) and religating to yield pBM3335 (SNF3-1ΔT). Plasmids pBM3576 and pBM3578, which contain the C-terminal tails of RGT2 and SNF3, respectively, fused to the ADH1 promoter, were obtained by cloning PCR products into pBM3531 (ADH1-HA-pRS424). The oligonucleotides used to amplify the RGT2 tail were OM1029: CGCGG-ATCCGGGGATTGACTTTGGAAG (BamHI site starts at ϩ1644) and OM1030: CGGCTCGAGTTATTGGGGGGAAGTGTATTG (XhoI site starts at the stop codon). The SNF3 tail was amplified using oligonucleotides OM1333 (CGCGGATTCAAACGAAGGGTTTGACAT-TAG; BamHI site starts at ϩ1629) and OM957 (BamHI site starts downstream of the stop codon).
The HXT-SNF3 chimeras were constructed as follows: pBM3273 (HXT1-SNF3 tail) was made by amplifying the region of HXT1 encoding its transmembrane region by PCR using oligonucleotides OM1027 (GGC-AAGCTTATGAATTCAACTCCCGATC) and OM1025 (AATGTCAAA-CCCTTCGTTTCGAAGAAAAAGACGTAAAAGTAAG) with pBM-2648 as template. The region of SNF3 encoding the C-terminal tail was amplified using oligonucleotides OM1092 (ACTTTTACGTCTTTTTCT-TCGAAACGAAGGGTTTGACATTAG; includes sequences from the 3Ј end of the HXT21 PCR product for priming in the third PCR described below) and OM957 with pBM3111 as template. The gel-purified products of these two PCRs were combined in a third reaction with OM1027 (primes at the 5Ј end of HXT1) and OM957 (primes at the 3Ј end of SNF3) to yield a chimeric product fusing HXT1 nucleotide 1536 to SNF3 nucleotide 1627 (relative to the ATG of each gene). The product was cleaved with HindIII and BamHI (sites incorporated at the end of primers OM1027 and OM957) and inserted between the HindIII and BamHI sites of pBM2974 [pRS426 (Christianson et al., 1992) containing the ADH1 promoter]. The ADH1 promoter was swapped for the HXT1 promoter by replacing the HpaI-XbaI fragment of pBM3435 [the 4.1 kb HindIII fragment containing~1200 bp of upstream promoter sequence and the entire HXT1 coding sequence inserted into pRS316 (Sikorski and Hieter, 1989) ] with the 1.8 kb HpaI-XbaI fragment of pBM3273 containing the HXTI-SNF3 fusion. pBM3454 (HXT2-SNF3 tail) was made by amplifying the region of HXT2 encoding its transmembrane region by PCR using oligonucleotides OM1028 and OM1026 (AATGT-CAAACCCTTCGTTTCAAAGAAAAACACGTAGAAGAATG) with pBM2649 as template. The region of SNF3 encoding the C-terminal tail was amplified using oligonucleotides OM1092 (includes sequences from the 3Ј end of the HXT2 PCR product for priming in the third PCR described below) plus OM957 with pBM3111 as template. The gelpurified products of these two PCRs were combined in a third reaction with OM1028 (primes at the 5Ј end of HXT2) and OM957 (primes at the 3Ј end of SNF3) to generate the chimeric product fusing HXT2 nucleotide 1510 to SNF3 nucleotide 1627 (relative to the ATG of each gene). The product of the reaction was cleaved with HindIII (cuts within HXT2) and inserted in the correct orientation in pBM2649 (a 2 μm plasmid containing HXT2; contributes the HXT2 2883 bp HindIII fragment containing the promoter and immediate 1203 nucleotides of coding sequence to the final plasmid). The Gal1::lacZ reporter (pBM690) contains the EcoRI-BamHI fragment of the GAL1 promoter from pBM252 (Johnston and Davis, 1984) fused to lacZ in the vector Ycp50. The construction of the SUC2::lacZ plasmid (pBM3082) was described by Ö zcan et al. (1997) .
β-galactosidase (β-Gal) assays β-galactosidase activity was assayed in permeabilized cells grown to mid-log phase as described previously (Yocum et al., 1984) . Activities are reported in Miller units. The mean activities are the averages of four to six assays of at least four independent transformants. Cells were pregrown on yeast nitrogen base (YNB) containing 5% glycerol plus 0.5% galactose lacking the appropriate amino acids, and transferred to YNB medium containing 4% glucose, 5% glycerol plus 0.5% galactose, or 5% glycerol plus 0.1% glucose, and incubated overnight before β-galactosidase activity was assayed.
